Portal vein thrombosis risk factors
|
Portal vein thrombosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Portal vein thrombosis risk factors On the Web |
|
American Roentgen Ray Society Images of Portal vein thrombosis risk factors |
|
Risk calculators and risk factors for Portal vein thrombosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
- There are no established risk factors for [disease name].
OR
- The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
- Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
Common Risk Factors
- Common risk factors in the development of toxic megacolon include:[1][2][3][4][5]
- Prothrombotic disorder
- Hyperhomocysteinemia
- Antiphospholipid syndrome
- Hormone replacement therapy
- Factor V Leiden mutation
- Protein C deficiency
- Polycythaemia vera
- Myeloproliferative syndrome
- Protein S deficiency
- Antitrombin III deficiency
- Disseminated coagulation
- Essential thrombocytosis
- Abdominal inflammation
- Chronic pancreatitis
- Cholangitis
- Acute pancreatitis
- Liver abscesses
- mbilical vein catheterization
- Cholecystolithiasis
- Polycystic liver disease
- Cirrhosis
- Prothrombotic disorder
Less Common Risk Factors
- Less common risk factors in the development of [disease name] include:
- Cancer
- Neuro-endocrine tumor
- Hepatocellular carcinoma
- Pancreatic cancer
- Angiomyxoma
- Unknown primary tumour
- Abdominal intervention
- Splenectomy
- Cholecystectomy
- Billroth II
- Radiofrequency ablation
- Gastropancreaticcystotomy
- Abdominal infection
- Bacteraemia
- Portal vein phlebitis
- Intestinal tuberculosis
- Sepsis
- Tuberculosis in psoas abscess
- Cancer
References
- ↑ Sogaard, Kirstine K; Astrup, Lone B; Vilstrup, Hendrik; Gronbaek, Henning (2007). "Portal vein thrombosis; risk factors, clinical presentation and treatment". BMC Gastroenterology. 7 (1). doi:10.1186/1471-230X-7-34. ISSN 1471-230X.
- ↑ Kinjo N, Kawanaka H, Akahoshi T, Tomikawa M, Yamashita N, Konishi K, Tanoue K, Shirabe K, Hashizume M, Maehara Y (2010). "Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension". Br J Surg. 97 (6): 910–6. doi:10.1002/bjs.7002. PMID 20474001.
- ↑ Chawla YK, Bodh V (2015). "Portal vein thrombosis". J Clin Exp Hepatol. 5 (1): 22–40. doi:10.1016/j.jceh.2014.12.008. PMC 4415192. PMID 25941431.
- ↑ Montenovo M, Rahnemai-Azar A, Reyes J, Perkins J (2017). "Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant". Exp Clin Transplant. doi:10.6002/ect.2016.0277. PMID 28621635.
- ↑ Zhang WW, Churchill S, Churchill P (1989). "Developmental regulation of D-beta-hydroxybutyrate dehydrogenase in rat liver and brain". FEBS Lett. 256 (1–2): 71–4. PMID 2806552.